SCYNEXIS, Inc.

NasdaqGM:SCYX 주식 보고서

시가총액: US$45.2m

SCYNEXIS 미래 성장

Future 기준 확인 5/6

SCYNEXIS은 연간 수입과 매출이 각각 48.7%와 30.8% 증가할 것으로 예상되고 EPS는 연간 49.2%만큼 증가할 것으로 예상됩니다.

주요 정보

48.7%

수익 성장률

49.2%

EPS 성장률

Pharmaceuticals 수익 성장23.7%
매출 성장률30.8%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트07 Nov 2024

최근 미래 성장 업데이트

SCYNEXIS, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 12
SCYNEXIS, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Recent updates

Is SCYNEXIS (NASDAQ:SCYX) Using Too Much Debt?

Aug 08
Is SCYNEXIS (NASDAQ:SCYX) Using Too Much Debt?

Lacklustre Performance Is Driving SCYNEXIS, Inc.'s (NASDAQ:SCYX) 32% Price Drop

Jun 19
Lacklustre Performance Is Driving SCYNEXIS, Inc.'s (NASDAQ:SCYX) 32% Price Drop

SCYNEXIS, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 12
SCYNEXIS, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

SCYNEXIS (NASDAQ:SCYX) Seems To Use Debt Rather Sparingly

Apr 04
SCYNEXIS (NASDAQ:SCYX) Seems To Use Debt Rather Sparingly

Scynexis: Update Following Restructuring Of GSK Deal

Apr 02

Lacklustre Performance Is Driving SCYNEXIS, Inc.'s (NASDAQ:SCYX) Low P/S

Feb 01
Lacklustre Performance Is Driving SCYNEXIS, Inc.'s (NASDAQ:SCYX) Low P/S

Does SCYNEXIS (NASDAQ:SCYX) Have A Healthy Balance Sheet?

Dec 21
Does SCYNEXIS (NASDAQ:SCYX) Have A Healthy Balance Sheet?

Little Excitement Around SCYNEXIS, Inc.'s (NASDAQ:SCYX) Revenues As Shares Take 28% Pounding

Sep 26
Little Excitement Around SCYNEXIS, Inc.'s (NASDAQ:SCYX) Revenues As Shares Take 28% Pounding

Is SCYNEXIS (NASDAQ:SCYX) Using Too Much Debt?

Aug 17
Is SCYNEXIS (NASDAQ:SCYX) Using Too Much Debt?

Scynexis: Uninvestible At This Point, Downgrading To A Sell Rating

Aug 26

SCYNEXIS Q2 2022 Earnings Preview

Aug 12

FDA accepts Scynexis' application to expand label for vaginal yeast infections treatment

Aug 01

SCYNEXIS gains after favorable data for antifungal agent in new indication

Jul 19

SCYNEXIS, Inc. (NASDAQ:SCYX) Analysts Just Cut Their EPS Forecasts Substantially

Apr 07
SCYNEXIS, Inc. (NASDAQ:SCYX) Analysts Just Cut Their EPS Forecasts Substantially

SCYNEXIS, Inc.: Speculative Buy, Michael Burry Sold, But I Am Buying

Mar 07

Some Analysts Just Cut Their SCYNEXIS, Inc. (NASDAQ:SCYX) Estimates

Feb 13
Some Analysts Just Cut Their SCYNEXIS, Inc. (NASDAQ:SCYX) Estimates

Is SCYNEXIS (NASDAQ:SCYX) Using Debt In A Risky Way?

Dec 03
Is SCYNEXIS (NASDAQ:SCYX) Using Debt In A Risky Way?

Scynexis: Leading The Yeast Infection Treatment Industry

Jul 27

Scynexis' Brexafemme qualifies for 10 years of exclusivity for vaginal yeast infections

Jun 09

FDA approves SCYNEXIS' BREXAFEMME vaginal yeast infections treatment

Jun 02

수익 및 매출 성장 예측

NasdaqGM:SCYX - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20261116517404
12/31/2025538N/A124
12/31/202410-22N/A-144
9/30/20249-36-22-22N/A
6/30/202410-35-10-10N/A
3/31/20241401017575N/A
12/31/2023140676060N/A
9/30/2023136724545N/A
6/30/2023136441010N/A
3/31/20236-91-83-83N/A
12/31/20225-63-80-80N/A
9/30/20224-78-83-83N/A
6/30/20223-49-78-77N/A
3/31/20222-34-71-70N/A
12/31/202113-33-56-55N/A
9/30/202113-46-46-46N/A
6/30/202112-45-39-39N/A
3/31/202112-53-36-36N/A
12/31/2020N/A-55-49-49N/A
9/30/2020N/A-27-46-46N/A
6/30/2020N/A-36-47-47N/A
3/31/20200-38-46-46N/A
12/31/20190-54-38-38N/A
9/30/20190-37-31-31N/A
6/30/20190-29-27-26N/A
3/31/20190-31-27-27N/A
12/31/20180-12-29-28N/A
9/30/20180-22-28-27N/A
6/30/20180-31N/A-27N/A
3/31/20180-24N/A-26N/A
12/31/20170-25N/A-25N/A
9/30/20170-21N/A-24N/A
6/30/20170-24N/A-26N/A
3/31/20170-28N/A-27N/A
12/31/20160-30N/A-29N/A
9/30/20160-35N/A-31N/A
6/30/20160-31N/A-30N/A
3/31/20160-30N/A-29N/A
12/31/20150-28N/A-25N/A
9/30/20151-23N/A-20N/A
6/30/20151-19N/A-18N/A
3/31/20151-11N/A-14N/A
12/31/20141-7N/A-9N/A
9/30/20144-42N/A-9N/A
6/30/20148-43N/A-6N/A
3/31/201412-47N/A-2N/A
12/31/201317-47N/A-4N/A

애널리스트 미래 성장 예측

수입 대 저축률: SCYX 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 2.6% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: SCYX (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: SCYX 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: SCYX 의 수익(연간 30.8% ) US 시장( 9% 보다 빠르게 성장할 것으로 예상됩니다. 9% 연간).

고성장 수익: SCYX 의 수익(연간 30.8% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: SCYX 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견